scispace - formally typeset
B

Berit Olsen Krogh

Researcher at Novo Nordisk

Publications -  33
Citations -  1811

Berit Olsen Krogh is an academic researcher from Novo Nordisk. The author has contributed to research in topics: Tissue factor pathway inhibitor & DNA. The author has an hindex of 18, co-authored 33 publications receiving 1733 citations. Previous affiliations of Berit Olsen Krogh include University of Würzburg & Kettering University.

Papers
More filters
Journal ArticleDOI

Recombination proteins in yeast.

TL;DR: Recently studies showing defects in homologous recombination and double-strand break repair in several human cancer-prone syndromes have emphasized the importance of this repair pathway in maintaining genome integrity.
Journal ArticleDOI

Catalytic mechanism of DNA topoisomerase IB.

TL;DR: This work used 5'-bridging phosphorothiolate-modified DNAs to implicate Lys-167 as a general acid catalyst and restored activity to the K167A mutant, whereas there was no positive thio effect for mutants R223A and H265A.
Journal ArticleDOI

Mutations in Mre11 phosphoesterase motif I that impair Saccharomyces cerevisiae Mre11-Rad50-Xrs2 complex stability in addition to nuclease activity.

TL;DR: The results show that the structural integrity of the Mre11-Rad50-Xrs2 complex is more important than the catalytic activity of theMre11 nuclease for the overall functions of the complex in vegetative cells.
Journal ArticleDOI

A poxvirus-like type IB topoisomerase family in bacteria

TL;DR: These findings imply an intimate evolutionary relationship between the poxvirus and bacterial type IB enzymes, and they engender a scheme for the evolution of topoisomerase IB and tyrosine recombinases from a common ancestral strand transferase in the bacterial domain.